WHO grants emergency approval for Pfizer-Bionic vaccine



[ad_1]

After several countries began vaccination campaigns with the “Pfizer-Biontech” vaccine, the World Health Organization grants emergency approval for the vaccine, following the growing number of coronavirus infections in the world.

  • Assent
    The “World Health Organization” approval of the “Pfizer-Biontech” vaccine will pave the way for countries wishing to use the vaccine quickly

Today, Thursday, the World Health Organization (WHO) granted its first emergency approval since the outbreak of the new Corona virus, “Covid-19”, for the “Pfizer-Bionic” vaccine, in a step that would pave the way for countries that wish to use the vaccine quickly, as expressed in the Declaration of the UN agency.

“This is a very positive step to ensure that everyone in the world has access to vaccines against the Covid-19 virus,” said Mariangela Simao, in charge of obtaining medicines at “World Health”.

Experts from the US Food and Drug Administration “FDA” said in a report that the “Pfizer-Biontech” vaccine against the Corona virus does not present any safety risk that would prevent it from obtaining a license.

The United States authorized the use of the “Pfizer-Bionic” vaccine against Corona and launched a mass vaccination campaign in the country.

And the world organization previously warned that despite the severity of the “Covid-19” pandemic, it is urgent to prepare for the “worst”.

A few days ago, the Swiss Institute gave its approval to license the “Pfizer-Biontech” vaccine, according to traditional procedures, and recommended its use for those over 16 years of age.

The European Medicines Agency has also approved the use of the Pfizer-Bionic vaccine.

The world registered more than 83 million cases of coronavirus, while the number of deaths exceeded one million and 800 thousand, according to the latest statistics.



[ad_2]